Patterns and predictors of use of warfarin and other common long-term medications in patients with atrial fibrillation

American Journal of Cardiovascular Drugs

Volumn 12, Issue 4, 2012, Pages 245-253

  Song, Xue ^a   Sander, Stephen D ^b   Varker, Helen ^a   Amin, Alpesh ^c  

^a IBM WATSON HEALTH   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

atrial fibrillation; warfarin

Indexed keywords

CARVEDILOL; LISINOPRIL; METFORMIN; PIOGLITAZONE; SIMVASTATIN; SITAGLIPTIN; VALSARTAN; WARFARIN;

ADULT; AGED; ARTICLE; ASPIRATION PNEUMONIA; BRAIN ISCHEMIA; CARDIOMYOPATHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG COST; DRUG USE; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOVOLEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEOPLASM; PATIENT COMPLIANCE; PERIPHERAL VASCULAR DISEASE; PNEUMONIA; PRIORITY JOURNAL; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; WARFARIN;

EID: 84863895136     PISSN: 11753277     EISSN: 1179187X     Source Type: Journal    
DOI: 10.2165/11632540-000000000-00000     Document Type: Article

References (20)

1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-5. doi:10.1001
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983-8
3. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146 (12): 857-67
4. Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 Suppl.): 429S-6S
5. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114 (7): e257-354
6. Lin LJ, ChengMH, Lee CH, et al. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation: a nationwide descriptive study in Taiwan. Clin Ther 2008 Sep; 30 (9): 1726-36
7. Gibson TB, Song X, Alemayehu B, et al. Cost-sharing, adherence, and healthoutcomes in patients with diabetes. Am J Manag Care. 2010 Aug; 16 (8): 589-600
8. Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005; 43 (6): 521-30
9. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006; 166 (17): 1836-41
10. Gallagher AM, Rietbrock S, Plumb J, et al. Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? J Thromb Haemost 2008; 6 (9): 1500-6
11. Ogilvie IM, Newton N, Welner SA, et al. Underuse of anticoagulant in atrial fibrillation: a systemic review. Am J Med 2010; 123 (7): 638-45
12. Bottoni N, Tritto M, Ricci R, et al. Adherence to guidelines for atrial fibrillation management of patients referred to cardiology departments: Studio Italiano multicentrico sul Trattamento della Fibrillazione Atriale (SITAF). Europace 2010; 12 (8): 1070-7
13. Tulner LR, Van Campen JP, Kuper IM, et al. Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study. Drugs Aging 2010; 27 (1): 39-50
14. Pisters R, de Vos CB, Nieuwlaat R, et al. Use and underuse of oral anticoagulation for stroke prevention in atrial fibrillation: old and new paradigms. Semin Thromb Hemost 2009; 35 (6): 554-9
15. Chernew M, Gibson TB, Yu-Isenberg K, et al. Effects of increased patient cost sharing on socioeconomic disparities in health care. J Gen Intern Med 2008; 23 (8): 1131-6
16. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA 2007; 298 (1): 61-9
17. Gibson TB, Ozminkowski RJ, Goetzel RZ. The effects of prescription drug cost sharing: a review of the evidence. Am J Manag Care 2005; 11 (11): 730-40
18. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clinical Therapy 2001; 23(8): 1296-310
19. Coyne KS, Paramore C, Grandy S, et al. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value in Health 2006; 9 (5): 348-56
20. Kim MH, Johnston SS, Chu BC, et al. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes 2011; 4: 313-20